ACC 2018

ACC 2018 Wrap-Up: Prof. Freek Verheugt’s Perspective

Tarek Nafee, M.D.

March 11, 2018

ACC 2018 Japanese Wrap-Up

Dr. Ogawa Presents Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

March 16, 2018

ACC 2018 Japanese Wrap-Up

Tarek Nafee, M.D.

March 11, 2018

ACC 2018 Italian Wrap Up

Dr. Gennaro Sardella Discusses Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

March 16, 2018

ACC 2018 Italian Wrap Up

Tarek Nafee, M.D.

March 12, 2018

MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery

Dr. PJ Devereaux and Dr. Gibson Discuss Subscribe on iTunes or Google…

Sadaf Sharfaei, M.D.

April 22, 2018

MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery

Tarek Nafee, M.D.

April 22, 2018

ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients

Dr. Schwartz and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

April 22, 2018

ODYSSEY Outcomes: Alirocumab Reduces MACE, Non-fatal MI, Ischemic Stroke, and All-Cause Mortality in ACS Patients

Tarek Nafee, M.D.

April 22, 2018

VEST trial: Prevention of Early Sudden Death Post-MI

Dr. Olgin and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

April 22, 2018

VEST trial: Prevention of Early Sudden Death Post-MI

Tarek Nafee, M.D.

April 22, 2018

SWAP 4: Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease

Dr. Angiolillo and Dr. Gibson Discuss Subscribe on iTunes or Google Play.

Sadaf Sharfaei, M.D.

April 22, 2018

SWAP 4: Pharmacodynamic Effects of Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease

Tarek Nafee, M.D.

April 22, 2018

ACC 2018 Daily Wrap-Up – March 10, 2018

Tarek Nafee, M.D.

March 11, 2018

Featured

ODYSSEY Demonstrates a Mortality Benefit in ACS Patients

Results of the much anticipated ODYSSEY Outcomes trial were presented today by…

Tarek Nafee, M.D.

March 23, 2018